In Vientiane, the capital city of Laos, a modern pharmaceutical manufacturing base is emerging steadily. As a representative of officially licensed chemical pharmaceutical enterprises in Laos, BigBear Pharma Co., Ltd. has shouldered the mission of addressing the local shortage of medicines and medical supplies since its inception, stepping firmly onto the global stage.
Deep Local Roots, Steady Growth Through Accumulation
BigBear Pharma was not built overnight. Jointly promoted by investors and the Minister of Health of Laos, the team conducted two full years of field investigations before selecting Vientiane as the factory site. Formal preparation began in 2020, and the high standard plant was completed and put into operation in 2021. In just two years, BigBear Pharma turned its development blueprint into a physical reality. From the very start of construction, the company invested heavily in industrial upgrading, building production workshops with internationally advanced standards and setting a new benchmark for Laos’ pharmaceutical industry.
Over the past two years, BigBear Pharma has pursued continuous innovation and sound operation, expanding its business scope. Its key economic indicators consistently rank among the top in Laos’ pharmaceutical sector. More than just a set of performance results, this marks a new chapter for the company in building a modern pharmaceutical group leading in Laos and world renowned globally.
An Industry Role Model with Product Driven Excellence
Star of Health, Care for All is the corporate mission BigBear Pharma always upholds. The company focuses on the research, development and production of high end generic drugs, with core products covering major therapeutic areas including liver diseases, pulmonary diseases, hematological malignancies and chronic disorders. Benefiting from its advantages in scale, technology, quality and brand, these products have received high recognition from the Ministry of Health of Laos and gained trust among medical professionals and patients.
Quality-Oriented Development Aligned with International Standards
At BigBear Pharma, quality is far more than a slogan — it is embedded in every production procedure. Since its establishment, the company has fully implemented Total Quality Management (TQM) and built a comprehensive, rigorous and efficient quality management system. All production processes strictly comply with GMP standards, and the enterprise has obtained certification under Laos’ latest GMP regulations, taking the lead in industry compliance.
BigBear Pharma also spares no effort in upgrading production equipment. It is equipped with internationally advanced facilities and testing instruments, including automatic granulation and packaging lines, soft capsule manufacturing equipment, hard capsule filling machines, high speed tablet presses, intelligent capsule packaging lines and high performance liquid chromatography devices. Every pharmaceutical product and every manufacturing step is produced under precise quality control.
Future Blueprint: Innovation-Led Development for World-Class Excellence
For future growth, BigBear Pharma has formulated a clear and ambitious development strategy. Upholding the philosophy of scientific development and the corporate tenet Human Health Comes First, Quality Is Always Paramount, the company will follow a development path of overall integration, innovation driven growth, optimization and upgrading, and refined and strengthened development. It aims to build itself into a modern pharmaceutical group featuring innovation leadership, intensive efficiency, open win win cooperation and sustainable prosperity within three to five years.
Setting off from Vientiane and marching toward the world, BigBear Pharma is writing an inspiring story of a Laotian pharmaceutical enterprise expanding onto the global arena with solid quality foundations and persistent innovation spirit.
